Molecular forecaster

September 5, 2024

Molecular Forecaster combines world-class computational tools with deep domain expertise to tackle the toughest challenges in early-stage drug discovery.

We develop and apply software to design small molecules to interact with RNA.

Industry news

April 16, 2025

The creation of training programs to meet the needs of the RNA therapeutics industry

Learn more

June 11, 2024

The creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies

Learn more

June 6, 2024

A new initiative to stimulate innovation and entrepreneurship in the RNA therapy sector in Quebec

Learn more

June 3, 2024

Quebec Launches AReNA to Become a Global Leader in RNA Therapies

Learn more

June 3, 2024

A group of partners are launching the CELLULE to accelerate the development of RNA therapies in Quebec

Learn more

May 29, 2024

The long-overlooked molecule that will define a generation of science

Learn more

Molecular forecaster

Industry news

Panagiotis Prinos appointed as Director of Réseau DePTAQ

AReNA attended FISQ

AReNA attends CASTL’s Open Door Day

Epitopea closes their $31 million pre-Series A financing.

Congratulations to the Nobel Prize winners in Medicine!

Congratulations to the 23 recipients of the D2R funding programs

The creation of training programs to meet the needs of the RNA therapeutics industry

The creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies

A new initiative to stimulate innovation and entrepreneurship in the RNA therapy sector in Quebec

Quebec Launches AReNA to Become a Global Leader in RNA Therapies

A group of partners are launching the CELLULE to accelerate the development of RNA therapies in Quebec

The long-overlooked molecule that will define a generation of science

Keep up to date with the latest news on RNA therapies